Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2012 1
2013 2
2014 4
2015 3
2016 9
2017 15
2018 6
2019 5
2020 10
2021 13
2022 11
2023 6
2024 7
2025 4
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.
Marchesini M, Gherli A, Simoncini E, Tor LMD, Montanaro A, Thongon N, Vento F, Liverani C, Cerretani E, D'Antuono A, Pagliaro L, Zamponi R, Spadazzi C, Follini E, Cambò B, Giaimo M, Falco A, Sammarelli G, Todaro G, Bonomini S, Adami V, Piazza S, Corbo C, Lorusso B, Mezzasoma F, Lagrasta CAM, Martelli MP, La Starza R, Cuneo A, Aversa F, Mecucci C, Quaini F, Colla S, Roti G. Marchesini M, et al. Among authors: liverani c. Nat Commun. 2024 Jun 4;15(1):4739. doi: 10.1038/s41467-024-48953-3. Nat Commun. 2024. PMID: 38834613 Free PMC article.
Editorial: Obesity and metabolism in endocrine-related cancers.
Calabrese C, Pellegata NS, Dellavalle S, Liverani C. Calabrese C, et al. Among authors: liverani c. Front Endocrinol (Lausanne). 2025 Jul 24;16:1661893. doi: 10.3389/fendo.2025.1661893. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40778282 Free PMC article. No abstract available.
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas.
Bongiovanni A, Liverani C, Foca F, Bergamo F, Leo S, Pusceddu S, Gelsomino F, Brizzi MP, Di Meglio G, Spada F, Tamberi S, Lolli I, Cives M, Marconcini R, Pucci F, Berardi R, Antonuzzo L, Badalamenti G, Santini D, Recine F, Vanni S, Tebaldi M, Severi S, Rudnas B, Nanni O, Ranallo N, Crudi L, Calabrò L, Ibrahim T. Bongiovanni A, et al. Among authors: liverani c. Eur J Cancer. 2024 Sep;208:114129. doi: 10.1016/j.ejca.2024.114129. Epub 2024 May 25. Eur J Cancer. 2024. PMID: 39002347 Free article. Clinical Trial.
Clinical and translational implications of immunotherapy in sarcomas.
Recine F, Vanni S, Bongiovanni A, Fausti V, Mercatali L, Miserocchi G, Liverani C, Pieri F, Casadei R, Cavaliere D, Falbo PT, Diano D, Ibrahim T, De Vita A. Recine F, et al. Among authors: liverani c. Front Immunol. 2024 Jun 25;15:1378398. doi: 10.3389/fimmu.2024.1378398. eCollection 2024. Front Immunol. 2024. PMID: 38983859 Free PMC article. Review.
Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
Lucarelli E, De Vita A, Bellotti C, Frisoni T, Vanni S, Guerrieri AN, Pannella M, Mercatali L, Gambarotti M, Duchi S, Miserocchi G, Maioli M, Liverani C, Ibrahim T. Lucarelli E, et al. Among authors: liverani c. Cancers (Basel). 2023 Oct 25;15(21):5132. doi: 10.3390/cancers15215132. Cancers (Basel). 2023. PMID: 37958307 Free PMC article. Review.
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.
Vanni S, De Vita A, Gurrieri L, Fausti V, Miserocchi G, Spadazzi C, Liverani C, Cocchi C, Calabrese C, Bongiovanni A, Riva N, Mercatali L, Pieri F, Casadei R, Lucarelli E, Ibrahim T. Vanni S, et al. Among authors: liverani c. Ther Adv Med Oncol. 2022 Jun 28;14:17588359221093973. doi: 10.1177/17588359221093973. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35782752 Free PMC article. Review.
The emerging role of cancer nanotechnology in the panorama of sarcoma.
Mercatali L, Vanni S, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Gurrieri L, Fausti V, Riva N, Genovese D, Lucarelli E, Focarete ML, Ibrahim T, Calabrò L, De Vita A. Mercatali L, et al. Among authors: liverani c. Front Bioeng Biotechnol. 2022 Oct 17;10:953555. doi: 10.3389/fbioe.2022.953555. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36324885 Free PMC article. Review.
Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors.
Gabellone S, Vanni S, Fausti V, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Cavaliere D, Pacilio CA, Ercolani G, Pieri F, Gurrieri L, Riva N, Jones R, De Vita A. Gabellone S, et al. Among authors: liverani c. Heliyon. 2024 Nov 22;10(23):e40596. doi: 10.1016/j.heliyon.2024.e40596. eCollection 2024 Dec 15. Heliyon. 2024. PMID: 39687122 Free PMC article. Review.
92 results